Target intelligence / Profile preview

Ovarian follicle maturation pathway (null)

Target
null
Molecular classification
Other (biological pathway, not a single molecule or receptor)
01

Overview

The ovarian follicle maturation pathway, also known as folliculogenesis, is a complex biological process in which primordial ovarian follicles grow and develop into mature preovulatory follicles capable of releasing an oocyte for fertilization. This process involves tightly regulated stages characterized by cell proliferation, differentiation, hormonal signaling, and apoptosis. Key cellular players include oocytes, granulosa cells, and theca cells. The progression from primordial to primary, secondary/antral, and finally preovulatory/Graafian follicles is orchestrated by endocrine signals—primarily gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone (FSH), luteinizing hormone (LH)—and local autocrine/paracrine factors produced within the ovary itself. Only one dominant follicle typically completes this journey each menstrual cycle in humans; most others undergo atresia via programmed cell death. The molecular regulation includes classical pathways such as WNT/β-catenin, insulin/IGF signaling, Notch signaling, Hedgehog pathways among others. Disruptions in this process can lead to reproductive pathologies including infertility or polycystic ovary syndrome.

Other names
FolliculogenesisOvarian follicle developmentFollicle growth and development
02

Mechanism of action

Not applicable to the entire pathway; mechanisms relate to modulation of hormone signaling and receptor activation within the process.

03

Biological functions

Cell proliferationCytodifferentiationSignal transduction (hormonal signaling)Apoptosis (atresia of non-dominant follicles)Hormone production (estrogen, inhibin)Oocyte maturation
04

Disease associations

Infertility/reproductive disordersPolycystic ovary syndrome (PCOS)Premature ovarian failure/insufficiency
05

Safety considerations

Not directly applicable; safety concerns are associated with drugs that modulate this pathway, such as risk of ovarian hyperstimulation syndrome with gonadotropin therapy.
06

Interacting drugs

Gonadotropins (FSH, LH analogs)

2 more in the full profile.

07

Biomarkers

Anti-Müllerian hormone (AMH) – reflects ovarian reserve and follicular activity.Estradiol – produced by growing follicles.Inhibin B – secreted by granulosa cells during early follicular phase.

Beyond the preview

Go deeper on Ovarian follicle maturation pathway (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovarian follicle maturation pathway (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call